Novavax Inc. closed 67.02% below its 52-week high of $23.86, which the company achieved on June 6th.

Dignitaries spoke, the Virginia Gentlemen crooned and Cavman mugged for photos with guests, all part of Friday’s grand opening for UVA’s newest location.

Dynavax Technologies Corporation sees strong Q4 results, with Heplisav-B boosting revenue. Click for my updated look at DVAX ...

Late last week in Morbidity and Mortality Weekly Report, authors from the Centers for Disease Control and Prevention (CDC) ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring ...